Le Lézard
Classified in: Health
Subjects: TRD, AVO

Emerald Professional Protection Products Reports - China Tariffs Start to Bite Infection Control Industry


SOMERSET, N.J., Nov. 5, 2019 /PRNewswire-PRWeb/ -- There is rising concern that users are going to cut back on disposable protection products in several areas and take dangerous, unnecessary risks. Risks like using products for a longer duration than intended or simply not using them at all. Will users take the precautions they are supposed to? Only time will tell.

We are not talking luxury items here, but essential infection control products. Many of these items are everyday items:

Food Service: Items such as beard covers, disposable inspection coats, jackets, hairnets, bouffant caps, paper packaging material, plastics and foils used to store and protect food, shrink film, plastic food containers, liners and many other items now attracting a 25% tariff.

Industrial: Respirators, protective clothing and safety shoes have been impacted.

Medical: Table examination paper, respirators, isolation gowns, protective clothing, surgical towels, and a myriad of other disposable products have attracted a 15% tariff.

Safety: Respirators, protective clothing, coveralls, everything from paint shop respirators to asbestos removal clothing. All have been impacted.

Importers of these products will end up absorbing 5 to 10% of the tariffs but the rest gets passed on to the distributor who in turn is forced to pass it along the consumer. The softening of the Chinese yuan versus the U.S. dollar has partially offset the increased costs associated with the tariffs. Profit margins will get squeezed, cost of goods will increase. We will continue to keep our customers informed as the situation remains very fluid.

In order to keep up with the latest news on tariffs affecting the disposable protection products industry please be sure to visit the Emerald Professional Products website, https://emeraldppp.com.

 

SOURCE Emerald Professional Protection Products


These press releases may also interest you

at 18:27
Andreozzi + Foote is deeply troubled by revelations of sexual abuse perpetrated by Ramon Garcia against patients at Carbon Health Urgent Care in Jenkintown and possibly other locations. Our client, Jane Doe, bravely stepped forward to share her...

at 18:14
SARC (Sarcoma Alliance for Research Through Collaboration) is proud to announce the launch of the Sarcoma Centers Registry https://sarctrials.org/sarcoma-centers/, a comprehensive, global resource facilitating...

at 18:08
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced with great respect and sorrow the unexpected passing last night of...

at 18:02
It takes a unique, special kind of dedication to become a nurse. For the nurses in First Nations and Inuit communities, it takes strength, resiliency, expertise, and most importantly, heart. It takes an understanding of the complex environment of...

at 17:44
On Tuesday, May 7, 2024, The Center for Discovery® (TCFD, The Center) honored Edward C. Sweeney, TCFD Board Chair, at the 24th annual Evening of Discovery Gala. The Gala was hosted by Mo Rocca, CBS Sunday Morning Correspondent, Humorist, and Creator...

at 17:30
PT217 is Phanes' first-in-class bispecific antibody targeting DLL3 and CD47; atezolizumab (TECENTRIQ®) is Roche's anti-PD-L1 monoclonal antibodyThe clinical supply agreement will focus on evaluating PT217 in combination with atezolizumab for the...



News published on and distributed by: